Investigating how the septal nuclei in the brain relate to alcohol use disorder
Official title: Involvement of the Septal Nuclei of the Human Brain in Alcohol Use Disorder - a Functional Magnetic Resonance Imaging Study
Run by Psychiatric Centre Rigshospitalet · NCT06866379 · Data updated 2026-11-12
This study is trying to see how certain parts of the brain are connected to alcohol use disorder by comparing brain activity in people with the disorder to those without it while they look at alcohol-related images.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 30 Years to 65 Years |
| Sex | All |
| Enrollment | 25 (estimated) |
| Sponsor | Psychiatric Centre Rigshospitalet Academic / other |
| Locations | 1 site (Frederiksberg) |
| Status | Recruiting |
| Started | May 7, 2025 |
| Main results expected | September 1, 2025 |
| Study ends | November 30, 2025 |
| Registry record updated | June 11, 2025 |
| Trial ID | NCT06866379 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with alcohol use disorder according to DSM-5 criteria.
✕Probably not a fit
Patients with other substance use disorders or severe mental health conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to explore the role of the septal nuclei in the human brain concerning alcohol use disorder (AUD) by using functional MRI (fMRI) imaging. Participants diagnosed with AUD will be compared to those without the disorder while being shown alcohol-related images in an MRI scanner. The study will include a total of 50 participants, with 25 having AUD and 25 serving as controls. The fMRI scans will measure neural activity through the BOLD signal, providing insights into the neuro-anatomical mechanisms underlying addiction.
Why it matters
Potential benefit: If successful, this study could enhance our understanding of the brain mechanisms involved in alcohol addiction, potentially leading to improved treatment strategies.
How similar studies have gone: While studies have explored brain mechanisms in addiction, the specific focus on the septal nuclei in humans is relatively novel and under-researched.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: * Diagnosed with alcohol use disorder (AUD) according to DSM-5, and alcohol dependence according to ICD-10 * An Alcohol Use Disorder Identification Test (AUDIT) score ≥ 15 * At least six heavy drinking days for the last 30 days, measured with the Time Line Follow Back (TLFB) method Exclusion criteria: * Diagnosis of schizophrenia spectrum disorder, paranoid psychosis, bipolar disorder, or mental retardation * Previous or current substance use disorder other than AUD and nicotine use disorder * History of alcohol withdrawal seizures within the past 5 years * Alcohol withdrawal symptoms defined as a CIWA-Ar score \> 9 at screening or at the fMRI session * Treatment with chlordiazepoxide or other benzodiazepine within the past 30 days * Other pharmacological treatment for AUD within the past 30 days * Treatment with GLP-1 analogues within the last 6 months * Urine tests positive for psychoactive drugs (cocaine, amphetamine, TCH, methadone, opioids, and benzodiazepines) at screening * DUDIT score ≥ 2/6 for females/males * Contraindications for undergoing an fMRI scan (magnetic implants, metal splinters, pacemaker, claustrophobia, etc.) * Females of childbearing potential who are either pregnant, breastfeeding or have the intention of becoming pregnant within the next month or are not using contraception appropriate for participating in a clinical study * Pregnancy (positive urine pregnancy test) * Unable to speak or understand Danish * Any condition that the investigator feels would interfere with trial participation
Where it's running
-
Psychiatric Center Copenhagen, Frederiksberg Hospital
Frederiksberg, Denmark Recruiting
Study contacts
- Study coordinator: Mette K Klausen, MD, PhD
- Email: mette.kruse.klausen@regionh.dk
- Phone: 004524835004
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Emotional Reactivity in Severe Alcohol Use Disorder and Depression Using Eye-Tracking and Physiological Measures
This study tests how people with severe alcohol use disorder, major depressive disorder, both conditions, or neither, recognize and react to emotions using eye-tracking and physiological data.
-
Thiamine to reduce brain injury in adults with alcohol use disorder
This trial tests whether thiamine can help protect the brain in adults with moderate to severe alcohol use disorder who drink daily.
-
Digital Recovery Support for Black adults with Alcohol Use Disorder in Detroit
This study tests whether a smartphone-based digital recovery program helps Black or African American adults in Detroit maintain their recovery from alcohol use disorder.
-
Path180: a computer-based skills program to help teens reduce alcohol use
This 8-week trial tests Path180, a computer-based skills training, added to usual care for teens 13–19 with alcohol use disorder to see if it improves daily-life coping skills and outcomes.
-
Effects of comorbidity on people with severe mental illness
This study tests how having both alcohol/substance use and a severe mental illness affects hospitalizations, medications, and social participation among adults followed at a mental health center.
-
Psilocybin in Alcohol Use Disorder with Depression (Relapse Prevention)
This study tests whether higher-dose psilocybin-assisted psychotherapy helps prevent relapse in adults with severe alcohol use disorder and depressive symptoms after detox.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.